Immunological considerations for laboratory staff and COVID-19 biosafety
The vulnerability of healthcare and laboratory to potential infection by the severe acute respiratory syndrome coronavirus 2 (SARS-CoV-2) virus has thus far been analyzed through the lens of the acute phase of the pandemic, including remote-based work, as well as emergency settings that are differen...
Saved in:
Main Authors: | Ambroise Kouame Kintossou (Author), Stephanie Villar (Author), Zisis Kozlakidis (Author) |
---|---|
Format: | Book |
Published: |
Elsevier,
2023-04-01T00:00:00Z.
|
Subjects: | |
Online Access: | Connect to this object online. |
Tags: |
Add Tag
No Tags, Be the first to tag this record!
|
Similar Items
-
Biosafety and biobanking: Current understanding and knowledge gaps
by: Julie Roux, et al.
Published: (2021) -
Factors influencing biosafety level and lai among the staff of medical laboratories
by: Anna Kozajda, et al.
Published: (2013) -
Biosafety and immunology: An interdisciplinary field for health priority
by: Jun Liu, et al.
Published: (2024) -
The incidence of Coronavirus disease 2019 (COVID-19) among vaccinated healthcare workers (HCWs): evidence for protection from hospitalisation from an Indonesian cohort
by: Zisis Kozlakidis
Published: (2023) -
Biosafety in the laboratories of the universities of Medical Sciences
by: Darien Nápoles Vega, et al.
Published: (2023)